can i change from tirzepatide to semaglutide you go vs. for weight loss—what's the difference? 🤔Both Experiences switching from semaglutide to

Neuropsychopharmacology 36(9):18591870 Kanoski SE et al (2013) Ghrelin signaling in the ventral hippocampus stimulates learned and motivational aspects of feeding via PI3K-Akt signaling

Here are actual dosing scenarios that researchers commonly encounter, broken down step by step with the math shown at every stage

Anecdotal reports from patients taking tirzepatide have also emerged on social media platforms and patient forums describing experiences with hair thinning or increased shedding

GIP was initially isolated from intestinal extracts and shown to have a potent insulinotropic effect.10, 15, 16 However, clinical studies demonstrated that, in hyperglycemic states, the insulinotropic action of GIP is inhibited, while GLP-1s function remains intact.17, 18 Recent research indicates that GIP is largely responsible for postprandial insulin secretion in T2DM, rather than the opposite.19 In preclinical studies, GIP receptor deficiency in mice leads to impaired glucose tolerance with reduced -cell function,20 while GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved beta cell function and glucose homeostasis.21 Collectively, GLP-1 and GIP seem to work in tandem with GLP-1 inhibiting glucagon secretion when the plasma glucose concentration is high, while GIP acts at lower glucose levels.17, 22 Thus, these two hormones could work together in T2DM as the consistent glucose-lowering effect of GLP-1 could potentiate the role of GIP, whose action is dependent upon the glycemic status

Availability of data and materials The datasets used and/or analyzed during the current study are available from the corresponding authors on reasonable request

Explore the infographic below to see how GLP-1s are transforming what ends up in shoppers cartsand how brands can stay ahead of the shift.